Lakefront Biotherapeutics NV 20-F for FY2021
Lakefront Biotherapeutics NV (LKFT)
20-F
2022-03-24
For: 2021-12-31
View Original
Added on
April 04, 2026
About this 20-F
Lakefront Biotherapeutics NV filed this 20-F on March 24, 2022, covering the fiscal year ended December 31, 2021 (FY2021).
Headline figures
Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 484.85M EUR
- up 1.4% from 478.05M EUR a year earlier
- Net loss
- 103.23M EUR
- compared with a net loss of 305.44M EUR a year earlier
- Diluted EPS
- -1.58 EUR
- compared with -4.69 EUR a year earlier